🇺🇸 FDA
Patent

US 10413548

Methods and compositions for the inhibition of Pin1

granted A61KA61K31/185A61K31/341

Quick answer

US patent 10413548 (Methods and compositions for the inhibition of Pin1) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Sep 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Sep 17 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K31/185, A61K31/341, A61K31/357, A61K31/365